高效液相色谱法测定乳膏剂中的联苯苄唑

 用高效液相色谱法测定了乳膏剂中联苯苄唑的含量。色谱柱为HypersilODS(2 0 0mm× 4.6mmi.d .,5 μm) ,以 0 .0 8mol/L三乙胺磷酸盐缓冲液 (pH 7.0 ) 乙腈 甲醇 (体积比为 2 0∶10∶70 )为流动相 ,在 2 5 4nm波长处检测。联苯苄唑质量浓度在 8 99mg/L～ 44 96mg/L范围内 ,其浓度与其峰面积的线性关系良好 (r =0 .9998)。该法灵敏度较高 ,重现性好。     

离子色谱法测定甘草提取物中草酸的含量

建立了用离子色谱测定甘草提取物中残留草酸含量的新方法。选用DionexIonPacAS11-HC阴离子分析柱(250mm×4mmi.d.),淋洗液为18mmol/LNaOH溶液,流速为1.0mL/min,抑制电导检测器检测。草酸色谱峰面积(Y)与浓度(X)在1.004～10.04mg/L内线性关系良好,线性回归方程为Y=0.1939X-0.0326,相关系数r=0.9999,检出限为0.012mg/L。样品回收率为96.8%～98.6%,相对标准偏差为0.78%。该方法简便、快速。     

全二维液相色谱的初步构建及其在山羊血清分离中的应用

以GFC/RP模式构建全二维液相色谱系统,第一维凝胶过滤色谱柱使用ShodexProteinKW 802. 5(300mm×8mmi.d. ),以0. 2mol/LNaH2PO4 (pH7. 0)的流动相在0. 15mL/min的流速下等度洗脱,第二维反相色谱柱使用HypersilBDSC18 (35mm×4. 6mmi.d. ),在3mL/min的流速下梯度洗脱。采用平行柱交替分析的形式作切换接口, 2. 5min切换一次,两个反相柱交替富集、分析第一维洗脱产物。以5个标准蛋白混合物的分离评价该系统,在单独一维模式中不能分离的样品在全二维液相色谱中得到了较好的分离,二维系统的总峰容量为225。与一维色谱相比,系统的总峰容量、分辨率得到较大提高。并用于山羊血清的纯化分析,对一维分离中的重合谱峰进行验证,对制备纯化有一定的实际意义。     

高效液相色谱法测定中药材补骨脂中补骨脂素和异补骨脂素的含量

 建立了测定中药材补骨脂中补骨脂素和异补骨脂素含量的高效液相色谱法。采用的色谱条件为:Hypersil ODS色谱柱(150 mm×4.6 mm i.d., 5 μm),以乙腈-水(体积比为30∶70)为流动相,检测波长为245 nm。在此条件下,补骨脂素、异补骨脂素和内标物联苯苄唑获得了较好的分离。补骨脂素和异补骨脂素质量浓度分别为0.50～10.0 mg/L 时,组分与内标的峰面积比值与质量浓度之间的线性关系良好(r=1.000),最低检测限为10 μg/L (S/N=3) 。所建立的方法用于不同     

高效液相色谱法测定α-萘乙酸

 采用高效液相色谱法 ,以HypersilC1 8( 4 6mmi d × 2 50mm ,5μm)为色谱柱 ,甲醇 水 磷酸 (体积比为 60∶40∶0 35,pH 3～ 4)为流动相 ,检测波长为 2 72nm ,测定了α 萘乙酸的质量分数。在 1 6mg/L～1 0 0 0mg/L时 ,质量浓度与峰面积线性关系良好 (r =0 9997) ,精密度RSD为 0 8% (n =5)。方法简便 ,准确。     

反相高效液相色谱法快速测定7种四环素类抗生素

建立了一种反相高效液相色谱梯度洗脱分离测定四环素类药物的新方法。采用DiamonsilTM C1 8ODS(2 5 0mm× 4 .6mmi.d ,5 μm)色谱柱 ,以甲醇 乙腈 0 .0 1mol/L草酸为流动相 ,流速 1.0mL/min ,2 70nm检测 ,在10min内分离检测四环素等 7种化合物。同时还研究了流动相组成、梯度条件、pH值、草酸浓度等因素对分离效果的影响。     

高效液相色谱法测定人血浆中的辛伐他汀

 建立了高效液相色谱法监测人口服辛伐他汀药物后的血药浓度。血样用环己烷-二氯甲烷(体积比为3.5∶1)提取,以洛伐他汀为内标,在237nm波长下检测;色谱柱:LichrospherC18(200mm×4.6mmi.d.,5μm),流动相:乙腈-水(体积比为70∶30);流速:1.2mL/min。血药浓度在0.25～50.0μg/L范围内与峰面积和内标峰面积的比值之间线性关系良好,日内及日间相对标准偏差(n=5)分别低于7.94%和8.58%,回收率高于93.3%。方法灵敏、准确、快速,适用于药物动力学和药效学研究。     

高效液相色谱法测定斯帕沙星注射液

 采用高效液相色谱法对斯帕沙星注射液中的主成分进行定量分析。色谱条件 :色谱柱为美国Waters公司的SymmetryC18(5 μm ,15 0mm× 3 9mmi d )不锈钢柱 ,检测波长为 2 98 8nm ,柱温 30℃ ,流动相为 0 2 %KH2 PO4缓冲液 (pH 3 2 ) CH3 CN CH3 OH(体积比为 80∶15∶5 )的混合溶液 ,进样量为 10 μL ,流速为 1 0mL/min。在该色谱条件下的测定结果是 :以斯帕沙星峰计算柱效为 15 30 0理论板数 /m ;斯帕沙星的线性范围为 39 94mg/L～ 199 6 8mg/L ,相关系数r =0 9999;平均加样回收率为 10 0 1% ,RSD为 0 72 %     

十二烷基苯磺酸锌毛细管气相色谱柱的制备及其用于含氧有机化合物的分析

采用汞塞动态法涂柱以十二烷基苯磺酸锌做为固定相制备了毛细管气相色谱柱 1 (固定液浓度为 9.3%W/V柱尺寸为 2 4m×0 .30mmi.d.) ,所用溶剂是丙酮 ,并且对柱性能进行了考察。实验表明这种色谱柱对C5 C8醇、酮、酯、C2 C8羧酸等具有较好的分离能力 ,尤其对强极性物质如羧酸 ,有独特的分离能力 ,峰形窄而对称 ,即使对痕量的羧酸也可直接做定量分析。     

离子色谱法测定啤酒及其酿造水中的无机阴离子

 采用阴离子分离柱YSA880 2 2A 9( 2 5 0mm× 4mmi.d .)分离 ,电渗析抑制器和电导检测器检测 ,以 2 4mmol/LNa2 CO3 3mmol/LNaHCO3(体积比为 2∶1)为流动相 ,以保留时间和标样添加法定性 ,标准曲线法定量 ,测定了啤酒及其酿造水中的无机阴离子。方法操作简便、快速 ,结果准确、可靠。     

Development of an HPLC method for the monitoring of tricyclic antidepressants in biofluids

A simple, rapid and sensitive HPLC method was developed and validated for the determination of four tricyclic antidepressants (TCAs): amitriptyline, doxepin, clomipramine (CLO) and imipramine, in pharmaceutical formulations and biological fluids. A Kromasil C(8 )analytical column (250 x 4 mm, 5 microm) was used for the separation, with a mobile phase consisting of 0.05 M CH(3)COONH(4) and CH(3)CN (45:55 v/v) delivered at 1.5 mL/min isocratically. Quantification was performed at 238 nm, with bromazepam (1.5 ng/microL) as the internal standard. The determination of TCAs in blood plasma was performed after protein precipitation. Urine analysis was performed by means of SPE using Lichrolut RP-18 Merck cartridges providing high absolute recoveries (> 94%). Direct analysis of urine was also performed after two-fold dilution. The developed method was fully validated in terms of selectivity, linearity, accuracy, precision, stability and sensitivity. Repeatability (n = 5) and between-day precision (n = 5) revealed RSD <13%. Recoveries from biological samples ranged from 91.0 to 114.0%. The absolute detection limit of the method was calculated as 0.1-0.6 ng in blood plasma and 0.2-0.5 ng in extracted urine or 0.4-0.7 in diluted urine. The method was applied to real samples of plasma from a patient under CLO treatment.     

Development of a validated HPLC method for the determination of four 1,4-benzodiazepines in human biological fluids

A simple and sensitive HPLC method was developed and validated for the determination of four frequently prescribed 1,4-benzodiazepines: alprazolam (ALP), bromazepam (BRZ), diazepam (DZP), and flunitrazepam (FNZ). Separation was achieved on an Inertsil C8 analytical (250 mm x 4 mm, 5 microm) column, after selective extraction of benzodiazepine drugs from biological matrices by means of SPE. Isocratic elution was performed with a mobile phase consisting of CH3COONH4, 0.05 M CH3OH, and CH3CN (33:57:10 by volume). Quantification was performed at 240 nm with mefenamic acid (6 ng/microL) as the internal standard. DSC-18 Supelco cartridges provided high absolute recoveries (81-115%). The developed method was fully validated in terms of selectivity, linearity, accuracy, precision, stability, and sensitivity. Repeatability (n = 8) and between-day precision (n = 8) revealed RSD <12%. Recoveries from biological samples ranged from 81.2 to 115%. The detection limit of the method was calculated as 3.3-10.2 ng in blood plasma and 2.6-12.6 ng in urine for 20 microL injection volume. The method was applied to spiked biological matrices. Moreover, the method was applied to real samples of urine after an oral administration.     

HPLC determination of cis-diamminedichloroplatinum(II) in plasma and urine with UV detection and column-switching

A method for determining cis-diamminedichloroplatinum(II) (CDDP), an anticancer drug, in plasma and urine by HPLC with UV detection and column-switching has been developed. Typical conditions were as follows. An apparatus was composed of two columns, two pumps, a UV detector, a sample injector with a 100 microL loop, a switching valve, a column oven and a recorder. A Rheodyne model 7125 sample injector was used as the switching valve. A precolumn (4.6 mm ID x 25 cm) was packed with MCI GEL CK10S (a strong cation exchanger), and an analytical column (4.6 mm ID x 5 cm) was packed with MCI GEL CDR10 (a strong anion exchanger). Both columns were connected in series via the switching valve. The CDDP-containing fraction of the effluent from the precolumn was loaded to the analytical column by column-switching and the effluent from the analytical column was monitored at 210 nm. An eluent of 0.3 M sodium dihydrogen phosphate was pumped at a flow rate of 1 mL/min and the columns were maintained at 40 degrees C. CDDP was eluted at about 11 min and the identity of the peak of CDDP on the chromatogram was confirmed by its 3-dimensional chromatogram and analysis of platinum in the column effluent. Under the conditions described above, a linear relationship was obtained between peak height and concentration of CDDP up to 100 microM. Correlation efficients were 0.998 for plasma and 0.999 for urine. The detection limit was 0.1 microM for CDDP in both plasma and urine (S/N = 3,0.005 AUFS). The reproducibility was within 3% for 10 determinations.(ABSTRACT TRUNCATED AT 250 WORDS)     

高效液相色谱梯度洗脱法测定唐威胶囊中的盐酸小檗碱及葛根素

 采用反相高效液相色谱梯度洗脱法,用ODS柱,以甲醇-醋酸-三乙胺-水为流动相,在230 nm处同时测定唐威胶囊中盐酸小檗碱及葛根素的含量。平均添加回收率(n=5)和RSD值分别为98.2%和1.6%(盐酸小檗碱);97.5%和1.8%(葛根素)。 关键词：     

高效液相色谱-离子阱质谱法测定生物体液中的痕量敌鼠和氯敌鼠

建立了中毒应急检测样品生物体液内痕量敌鼠和氯敌鼠的高效液相色谱-离子阱质谱定性定量检测方法。全血样品由甲醇/乙腈(50/50, v/v)沉淀蛋白后再经Oasis HLB固相萃取小柱净化富集,尿液样品直接经同类小柱净化富集。采用Extend C18柱分离,以乙酸铵-乙酸(0.02 mol/L, pH 5.5)缓冲溶液和甲醇(15/85, v/v)溶液为流动相,使用电喷雾电离负离子多反应监测模式检测敌鼠和氯敌鼠。对全血样品,敌鼠和氯敌鼠分别在1.0～200.0 μg/L和0.5～100.0 μg/L范围内呈良好的线性关系,回收率分别在90.1%～92.2%和87.6%～93.4%范围内,日内相对标准偏差(RSD)分别小于6.8%和7.1%,日间RSD分别小于9.9%和10.9%,定量限分别为1.0 μg/L和0.5 μg/L。对尿液样品,敌鼠和氯敌鼠分别在0.2～ 40.0 μg/L和0.1～20.0 μg/L范围内呈良好的线性关系,回收率分别在90.1%～94.5%和90.0%～ 98.0%范围内,日内RSD分别小于6.1%和7.3%,日间RSD分别小于8.9%和11.2%,定量限分别为0.2 μg/L和0.1 μg/L。本方法简便、灵敏,能满足敌鼠和氯敌鼠中毒病人的临床快速诊断要求。     

Quantitative determination of piritramide in human plasma and urine by off- and on-line solid-phase extraction liquid chromatography coupled to tandem mass spectrometry

A method for the liquid chromatography/tandem mass spectrometric (LC/MS/MS) quantification of piritramide, a synthetic opioid, in plasma after conventional off-line solid-phase extraction (SPE) and in urine by on-line SPE-LC/MS/MS in positive electrospray mode was developed and validated. Applicability of the on-line approach for plasma samples was also tested. Deuterated piritramide served as internal standard. For the off-line SPE plasma method mixed cation-exchange SPE cartridges and a 150 x 2 mm C18 column with isocratic elution were used. For the on-line SPE method, a Waters Oasis HLB extraction column and the same C18 analytical column in a column-switching set-up with gradient elution were utilized. All assays were linear within a range of 0.5-100 ng/mL with a limit of detection of 0.05 ng/mL. The intra- and interday coefficients of variance ranged from 1.3 to 6.1% for plasma and 0.5 to 6.4% for urine, respectively. The extraction recovery for the off-line plasma assay was between 90.7 and 100.0%. Influence of matrix effects, and freeze/thaw and long-term stability were validated for both approaches; influence of urine pH additionally for quantification in urine.     

固相萃取-液相色谱-串联质谱法同时测定尿液中9种多环芳烃代谢物

建立了固相萃取-液相色谱-串联质谱同时测定尿中2-羟基萘、1-羟基萘、2-羟基芴、3-羟基菲、1-羟基芘等9种多环芳烃代谢物的液相色谱-串联质谱测定方法。尿样中结合态的多环芳烃代谢物在β-葡萄糖苷酸酶-芳基硫酸酯酶缓冲液(pH 5.0)作用下,于37℃水浴中避光水解4 h后,以C18固相萃取小柱富集、净化,以甲醇洗脱,采用Waters Symmetry C18色谱柱,流动相为乙腈-0.2%氨水(72∶27,V/V)等度淋洗分离后进入质谱测定。在喷雾电压4 kV,毛细管温度300℃下,以3-羟基菲13C为内标,采用SRM模式负离子扫描方式测定,内标法定量。9种多环芳烃代谢物在尿中的线性范围为0.90～100μg/L;相关系数为0.9970～0.9990;回收率为79.0%～119.8%;相对标准偏差为4.3%～12.4%;检出限为0.04～0.90μg/L;结果表明,本方法可用于尿中9种多环芳烃代谢物的测定。     

高效液相色谱-串联质谱法同时测定水体和沉积物中12种有机磷酸酯类化合物

建立了高效液相色谱-质谱联用技术结合固相萃取和液液萃取方法检测水体和沉积物中12种磷酸酯类(OPEs)化合物残留的方法.水样样品经HLB固相萃取柱富集,乙酸乙酯洗脱两次,沉积物样品以乙腈超声萃取,旋转蒸发至干,用超纯水稀释后重复水样处理步骤,采用ZORBAX Eclipse Plus C18色谱柱(150 mm×2.1 mm, 3.5 μm)进行分离,以0.2%甲酸-甲醇作为流动相进行梯度洗脱,采用正离子MRM监测模式,外标法定量分析.水样中,12种OPEs在0.05、0.10和0.50 μg/L加标水平下,除TMP (28.5%~47.8%)和TEHP (22.4%~73.8%) 外,其余目标化合物的平均回收率为66.4%~115.0%,相对标准偏差为0.5%~9.1%,方法定量限(MOQ)为0.001~0.050 μg/L;沉积物中,在5、10和50 μg/kg加标水平下,除TMP(35.7%~44.9%)、TCEP (31.2%~48.9%)外,其余目标化合物的平均回收率为65.9%~120.0%,相对标准偏差为0.01%~9.5%,方法定量限(MOQ)为0.02~2.0 μg/kg(dw).基于上述方法对太湖水样和沉积物样品中目标化合物定量检测分析,∑OPEs含量分别为0.1~1.7 μg/L和8.1~420 μg/kg dw.     

Online trace enrichment to determine pyrethroids in river water by HPLC with column switching and photochemical induced fluorescence detection

The potential of online trace enrichment on a highly apolar short column in LC was evaluated for the determination of pyrethroids in river water. Twelve millilitres of water samples, modified with 8 mL ACN (ACN/water 40:60, v/v), were passed through 50 x 4.6 mm ID first separation column packed with 5 microm Hypersil Elite C18. Pesticides were preconcentrated in this column while the matrix background was eluted to waste. Separation of pesticides was performed on a 3.5 microm symmetric C18 column (250 x 4.6 mm ID) with an ACN step gradient as mobile phase and fluorescence detection was used after postcolumn derivatization by using UV light. The use of photochemically induced fluorescence for detection improved sensitivity and selectivity. Quantification limits ranged from 0.05 to 0.1 microg/L and pesticide recoveries at two concentration levels (0.1 and 0.5 microg/L) were between 93.1 and 118.6%, with RSD between 2.5 and 7.5% (n = 3) in river water samples. No matrix effect was detected.     

Development of a validated HPLC method for the determination of four penicillin antibiotics in pharmaceuticals and human biological fluids

A quantitative method for the determination of four penicillin antibiotics, amoxicillin (AMO), oxacillin (OXA), cloxacillin (CLO), and dicloxacillin (DICLO), has been developed. Separation was achieved on an Inertsil ODS-3 (250 x 4 mm, 5 microm) column after selective extraction of penicillin drugs from biological matrices by means of SPE. Gradient elution with a mobile phase consisting of 0.1% TFA (pH 1) and ACN, and PDA detection with monitoring at 240 nm was applied. Salicylic acid (5 ng/microL) was used as the internal standard. RP-8 Adsorbex Merck cartridges provided high absolute recoveries (98-101%). The developed method was fully validated in terms of selectivity, linearity, accuracy, precision, stability, and sensitivity. Repeatability (n = 8) and between-day precision (n = 8) revealed RSD <10%. Recoveries from biological samples ranged from 91 to 103%. The detection limits were estimated as 3.3 ng for AMO, OXA, and CLO, and 6.6 for DICLO in blood plasma. LOD in whole blood and urine was 6.6 ng. Injection volume was 20 microL. The method was applied to commercially available AMO containing pharmaceuticals and spiked biological matrices. The method was also applied to biological samples after AMO oral administration, where the drug was successfully identified and quantified.